Th17 can promote the invasion of EAC cells but plays a protective role in ESCC by enhancing the cytotoxic effect of natural killer (NK) cells and activating CD1A + DC in tumors (Liu et al., 2017; Melo et al., 2020). The gene discussed is CD1A; the disease is esophageal squamous cell carcinoma.